Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
12,469,279
-
Shares change
-
+11,545,225
-
Total reported value, excl. options
-
$258,260,359
-
Value change
-
+$239,918,359
-
Number of buys
-
45
-
Price
-
$20.87
Significant Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q4 2015
47 filings reported holding CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share as of Q4 2015.
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,469,279 shares
of 165,547,872 outstanding shares and own 7.53% of the company stock.
Largest 10 shareholders include FMR LLC (5,403,643 shares), DEERFIELD MANAGEMENT CO (946,022 shares), WELLINGTON MANAGEMENT GROUP LLP (749,055 shares), Redmile Group, LLC (738,356 shares), PERCEPTIVE ADVISORS LLC (642,047 shares), BVF INC/IL (608,848 shares), VHCP Management II, LLC (603,031 shares), Cormorant Asset Management, LLC (371,023 shares), Tekla Capital Management LLC (328,059 shares), and PUTNAM INVESTMENTS LLC (325,000 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.